Adam Schechter Insider Profile
4 Followers
Adam Schechter, Director at DaVita, holds 5.97K shares in DaVita (Ticker: DVA), holds 102.56K shares in Labcorp Holdings (Ticker: LH), holds 55.41K shares in Merck & Company (Ticker: MRK).
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
-1.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Adam Schechter holds in companies
Most Profitable Insider Trade
The most profitable trade made by Adam Schechter
Adam Schechter's Trading History
DaVita
Aug 18, 2026
Director
Uninformative Buy
―
$1.10M
Merck & Company
Nov 02, 2018
EVP & Pres-Global Human Health
Uninformative Buy
10.92M
$8.33M
Labcorp Holdings
Aug 12, 2026
President & CEO, Director
Uninformative Sell
1.50M
$33.53M
List of latest transactions for each holding click on a transaction to see Adam Schechter's performance on stock
You May Also Like
Adam Schechter insider profile FAQ
What is the percentage of profitable transactions made by Adam Schechter?
The percentage of profitable transactions made by Adam Schechter is 50%.
What is the average return per transaction made by Adam Schechter?
The average return per transaction made by Adam Schechter is -1.50%.
What stocks does Adam Schechter hold?
Adam Schechter holds: DVA, MRK, LH stocks.
What was Adam Schechter’s latest transaction?
Adam Schechter latest transaction was an Uninformative Buy of ―.
What was Adam Schechter's most profitable transaction?
Adam Schechter’s most profitable transaction was an Informative Buy of LH stock on May 12, 2014. The return on the trade was 16.40%.
What is Adam Schechter's role in DaVita?
Adam Schechter's role in DaVita is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.